Levaquin Articles
Daiichi Sankyo launches flu drug Inavir inhaler in Japan; expands deal with ArQule; gets favorable patent ruling against Lupin
20 October 2010
Daiichi Sankyo ups profit forecast by 13% on expected rupee gain related to Ranbaxy; files flu drug in Japan
1 February 2010
Better times ahead for Switzerland’s Basilea
26 October 2009
Further 318 generics added to Japan's NHI list
19 May 2009
Japan stock market week to April 27, 2009
28 April 2009
J&J 1st qtr hit by market drop; keeps guidance
15 April 2009
Mpex Pharma to raise up to $40M
16 February 2009
Japan stock market week to Nov 24, 2008
24 November 2008
Japan stock market week to Nov 3, 2008
10 November 2008
Expert updates on current CF pipeline
13 October 2008
Eight drugs get nod from EMEA's COMP
21 July 2008
Black box warnings on fluoroquinolone
14 July 2008
AMDL to buy China pharma distributor
7 July 2008
Strong data for Bayer's Avelox in CAP
26 May 2008
Wyeth withdraws US CAP Tygacil application
5 May 2008
Japan stock market week to February 4 , 2008
14 February 2008
J&J's 4th-qtr 2007 sales jump 16.6%, EPS up 11%
28 January 2008
US Public Citizen group sues the FDA over antibiotics warnings
14 January 2008
Wyeth submits Tygacil sNDA for CAP
29 October 2007
FDA clears new indication for Ortho-McNeil's Levaquin
24 September 2007
Wyeth to submit Tygacil sNDA for CAP
23 July 2007
Japan stock market week to May 14, 2007
21 May 2007
Daiichi Sankyo completes post-merger integration
9 April 2007
FDA extends Levaquin marketing exclusivity
26 March 2007
Japan stock market week to June 25, 2007
7 February 2007
Patent expiry will "constrain" antibacterial market
15 January 2007
AMDL to produce levofloxacin in China
15 January 2007
Japan stock market week to Nov 6, 2006
13 November 2006
Daiichi Sankyo's first-half profit jumps 35.3%
13 November 2006
Wyeth's Tygacil comparable to J&J's Levaquin
9 October 2006
Cethromycin effective against CAP and ABECB
9 October 2006
UPDATE: ICAAC 2006 sees strong data on next-gen antibiotics: Tygacil, ceftaroline, cethromycin
9 October 2006
Bayer's Avelox "as effective" as potent combo regimen for CA pneumonia
11 September 2006
FDA petitioned for warnings on fluoroquinolones
4 September 2006
Japan stock market week to June 12, 2006
19 June 2006
Japan stock market week to May 15, 2006
22 May 2006
Daichii Sankyo's 2005/6 net income up 9.7%
22 May 2006
S-P announces positive Avelox study data
17 April 2006
Daiichi Sankyo sees increase in 2005 income
20 February 2006
Japan stock market week to Feb 13, 2006
20 February 2006
Japan stock market week to Feb 6, 2006
13 February 2006
S-Ps Avelox outperforms Levaquin in CAP study
6 February 2006
Japan stock market week to Jan 23
30 January 2006
J&J's 4th-qtr 2005 sales drop 1.1% on low Rx
30 January 2006
Daiichi Sankyo: 8% half-year income rise
12 December 2005
Better-than-expected 1st qtr for Daiichi
22 August 2005
Japan stock market week to August 15
22 August 2005
Stock Commentary - Tokyo
15 August 2005
Ortho's Levaquin gets US FDA approval
15 August 2005
Japan stock market week to August 8
15 August 2005
Japan stock market week to June 6
13 June 2005
Daiichi FY2005 net income soars 39%
16 May 2005
Japan stock market week to May 2
9 May 2005
Japan stock market week to March 28
4 April 2005
Teva gains tentative US OK for generic levofloxacin
21 February 2005
Japan stock market week to January 31
7 February 2005
Dragon completes Oriental Wave buy
24 January 2005
Japan stock market week to January 10
17 January 2005
Ortho-McNeil's Levaquin patent upheld in USA
10 January 2005
US sales decline hits Santen results
22 November 2004
Daiichi sees first-half revenues fall 2%
15 November 2004
Tokyo pharma stocks - week to October 4
11 October 2004
Oscient's Factive available in USA
20 September 2004
Daiichi Pharma
23 August 2004
Factive effective for CAP and ABECB
16 August 2004
Tokyo pharma stocks - week to August 9
16 August 2004
J&J's Levaquin gets FDA OK for new use
26 July 2004
US sales growth boosts Santen results
31 May 2004
Tokyo pharma stocks - week to May 17
24 May 2004
Bayer continues to focus on anti-infectives
10 May 2004
J&J's sales leap 17.7% for 1st-qtr 2004
19 April 2004
Tokyo pharma stocks - week to March 8
15 March 2004
Daiichi FY net income forecast to soar 92%
1 March 2004
Tokyo pharma stocks - week to Feb 16
23 February 2004
Tokyo pharma stocks - week to Jan 5
5 January 2004
Santen and J&J sign accord
5 January 2004
Japanese stock commentary - Nov 3
10 November 2003
Stock Commentary - Tokyo
10 November 2003
Cravit boosts Daiichi, beats expectations
10 November 2003
Tokyo pharma stocks - week to Oct 13
20 October 2003
Tokyo pharma stocks - week to August 4
11 August 2003
Stock Commentary - Tokyo
11 August 2003
Tokyo pharma stocks - week to May 12
19 May 2003
Santen files for ocular levofloxacin in USA
12 May 2003
Tokyo pharma stocks - week to May 5
12 May 2003
Daiichi donates SARS drug to China
12 May 2003
Daiichi's profits set to fall in fiscal 2003
14 April 2003
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
